ALVO Alvotech

Nasdaq alvotech.com


$ 8.98 $ 0.48 (5.65 %)    

Wednesday, 15-Oct-2025 15:59:46 EDT
QQQ $ 602.76 $ 4.22 (0.71 %)
DIA $ 463.02 $ 0.00 (0 %)
SPY $ 665.21 $ 2.94 (0.44 %)
TLT $ 90.75 $ -0.20 (-0.22 %)
GLD $ 387.56 $ 6.60 (1.73 %)
$ 8.98
$ 8.74
$ 8.76 x 500
$ 9.18 x 205
$ 8.70 - $ 9.05
$ 7.35 - $ 13.70
510,520
na
2.71B
$ 0.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 morgan-stanley-upgrades-alvotech-to-overweight-announces-14-price-target

Morgan Stanley analyst Thibault Boutherin upgrades Alvotech (NASDAQ:ALVO) from Equal-Weight to Overweight and announces $14 ...

 2-advanz-pharma-alvotech-move-closer-to-launching-affordable-asthma-and-allergy-treatment-in-europe-after-ema-filing-acceptance

Advanz Pharma Holdco Limited ("Advanz Pharma"), a UK headquartered global pharmaceutical company with a strategic focus...

 deutsche-bank-upgrades-alvotech-to-buy-announces-14-price-target

Deutsche Bank analyst Niall Alexander upgrades Alvotech (NASDAQ:ALVO) from Hold to Buy and announces $14 price target.

 alvotech-wins-eu-panel-backing-for-biosimilar-to-prolia-and-xgeva-expanding-affordable-bone-disease-treatments

Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for pa...

 alvotech-and-advanz-pharma-win-key-eu-backing-for-simponi-biosimilar-to-treat-arthritis-and-colitis

Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for pa...

 alvotechs-commercialization-partner-in-japan-fuji-pharma-receives-marketing-approval-for-three-new-biosimilars-from-japanese-ministry-of-health-labor-and-welfare

Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for pa...

 alvotechs-earnings-a-preview
Alvotech's Earnings: A Preview
08/12/2025 15:01:24

 alvotech-sa-files-for-mixed-shelf-size-not-disclosed

 - SEC Filing

 why-is-alvotech-stock-trading-higher-on-wednesday

Alvotech acquires Swiss packaging firm Ivers-Lee to boost biosimilar production capacity ahead of three 2025 launches.

 alvotech-secures-interest-rate-reduction-on-11b-loan-saving-82m-in-first-year-payments

Alvotech (NASDAQ:ALVO, ALVO SDB, the "Company"))), a global biotech company specializing in the development and manufac...

 alvotech-kashiv-and-advanz-pharma-report-top-line-results-for-xolair-biosimilar-avt23-in-confirmatory-efficacy-study

Alvotech, a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients world...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION